Exicure (XCUR) Other Working Capital Changes (2016 - 2026)
Exicure (XCUR) reported Other Working Capital Changes of -$2000.0 for Q1 2026, up 96.61% on a YoY basis from -$1017.2 in Q1 2025, and down 166.67% quarter-over-quarter from $3000.0 in Q4 2025.
Exicure (XCUR) Other Working Capital Changes (2016 - 2026) Analysis & Trends
Exicure has reported Other Working Capital Changes for 11 years, with the latest figure at -$2000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes rose 96.61% year-over-year to -$2000.0; the trailing twelve-month figure through Mar 2026 stood at $18000.0 (up 102.2% YoY), and the FY2025 full-year result was -$39000.0, up 96.01% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$2000.0, down from $3000.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $7.1 million in Q4 2022, with the low at -$5.1 million in Q3 2022.
- Historically, Other Working Capital Changes has averaged -$100705.9 across 5 years, with a median of -$157000.0 in 2023.
- Annual changes were most pronounced in 2024 — Other Working Capital Changes slumped 1741.67% — and 2025, when it soared 166.15%.
- Exicure's Other Working Capital Changes stood at $7.1 million in 2022, then sank by 108.59% to -$609000.0 in 2023, then jumped by 39.24% to -$370000.0 in 2024, then soared by 100.81% to $3000.0 in 2025, then plunged by 166.67% to -$2000.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$2000.0 (Q1 2026), $3000.0 (Q4 2025), and $127000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Exicure | 19.38 Mn | 16.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,000.00 |
| Mar 31, 2026 | -2,000.00 |
| Dec 31, 2025 | 3,000.00 |
| Dec 31, 2025 | 3,000.00 |
| Sep 30, 2025 | 127,000.00 |
| Sep 30, 2025 | 127,000.00 |
| Jun 30, 2025 | -110,000.00 |
| Jun 30, 2025 | -110,000.00 |
| Mar 31, 2025 | -59,000.00 |
| Mar 31, 2025 | -59,000.00 |
| Dec 31, 2024 | -370,000.00 |
| Dec 31, 2024 | -370,000.00 |
| Sep 30, 2024 | -192,000.00 |
| Sep 30, 2024 | -192,000.00 |
| Jun 30, 2024 | -197,000.00 |
| Jun 30, 2024 | -197,000.00 |
| Mar 31, 2024 | -218,000.00 |
| Mar 31, 2024 | -218,000.00 |
| Dec 31, 2023 | -609,000.00 |
| Dec 31, 2023 | -609,000.00 |